- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02451280
Unilateral vs. Bilateral Approaches to Hybrid Stroke Rehabilitation
July 6, 2016 updated by: Chang Gung Memorial Hospital
The aim of the project is to compare the effects of unilateral hybrid therapy [unilateral robot-assisted therapy (RT)] + unilateral arm training (UAT)] and bilateral hybrid therapy [bilateral RT + bilateral arm training (BAT)] on motor function, daily function, mobility, life quality, and motor control strategy in stroke patients.
Study Overview
Status
Unknown
Conditions
Study Type
Interventional
Enrollment (Anticipated)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kwei-Shan, Tao-Yuan, Taiwan, 333
- Not yet recruiting
- Chang Gung memorial hospital
-
New Taipei City, Taiwan
- Recruiting
- Taipei Hospital, Ministry of Health and Welfare
-
-
Toayuan county
-
Kwei-shan, Toayuan county, Taiwan, 333
- Not yet recruiting
- Lo-Sheng Sanatorium and Hospital
-
Contact:
- Wu
- Phone Number: 886-3-211-8800 Ext. 5761
- Email: cywu@mail.cgu.edu.tw
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 78 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- ≥3 months onset from a first-ever unilateral stroke;
- minimal motor criteria to receive CIT (i.e., ≥10º wrist extension and ≥ 10º extension at the thumb and any two other digits);
- an initial FMA-UE score of 10 to 56, indicating mild to moderate and moderate to severe upper extremity motor impairment;
- no excessive spasticity in any of the joints of the affected arm (shoulder, elbow, wrist, and fingers);
- able to follow instructions and perform the study tasks (Mini Mental State Examination ≥ 22);
- without upper extremity fracture within 3 months;
- no participation in any rehabilitation experiments or drug studies during the study period; and (8) willing to provide written informed consent.
Exclusion Criteria:
- acute inflammatory disease;
- major health problems or poor physical condition that might limit participation; and (3) attend any other study in recent 3 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Unilateral Hybrid Intervention Group
Participants will receive 6 weeks of bilateral RT training using the BMT and UAT training in each session.
|
For the unilateral RT training, participants will practice with their affected arms following a unilateral training protocol of BMT for 45 minutes (Yang, et al., 2012).
For the UAT training, participants will receive training of the affected UL in functional tasks with behavioral shaping for 45 minutes (Lin, Wu, et al., 2009).
|
Experimental: Bilateral Hybrid Intervention Group
Participants will receive 6 weeks of bilateral RT training using the BMT and BAT training in each session.
|
For the bilateral RT training, patients will focus on training involving both arms using the BMT robot for 45 minutes.
During the 45 minutes BAT training, participants will receive training in tasks focusing on bilateral symmetric or alternating movements of both ULs.
|
Experimental: Robot-Assisted Training Group
Participants will receive 6 weeks of RT training using the BMT in each session.
|
The RT intervention will be matched in duration and intensity with the hybrid interventions.
Participants in the RT group will practice on the BMT with bilateral protocols for 90 minutes.
The tasks will be tailored according to the level
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change scores of Fugl-Meyer assessment(FMA)
Time Frame: baseline, 3 weeks, 6 weeks, 18 weeks
|
baseline, 3 weeks, 6 weeks, 18 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Wolf Motor Function Test (WMFT)
Time Frame: baseline, 6 weeks
|
baseline, 6 weeks
|
Change scores of Box and block test (BBT)
Time Frame: baseline, 3 weeks, 6 weeks, 18 weeks
|
baseline, 3 weeks, 6 weeks, 18 weeks
|
Change scores of Action research arm test (ARAT)
Time Frame: baseline, 3 weeks, 6 weeks
|
baseline, 3 weeks, 6 weeks
|
Change scores of Medical Research Council scale (MRC)
Time Frame: baseline, 3 weeks, 6 weeks
|
baseline, 3 weeks, 6 weeks
|
Change scores of Modified Ashworth scale (MAS)
Time Frame: baseline, 3 weeks, 6 weeks
|
baseline, 3 weeks, 6 weeks
|
Change scores of Myoton
Time Frame: baseline, 6 weeks
|
baseline, 6 weeks
|
Change scores of Chedoke Arm and Hand Activity Inventory (CAHAI)
Time Frame: baseline, 6 weeks
|
baseline, 6 weeks
|
Change scores of Functional independent measure (FIM)
Time Frame: baseline, 3 weeks, 6 weeks
|
baseline, 3 weeks, 6 weeks
|
Change scores of Stroke Impact Scale (SIS 3.0 version)
Time Frame: baseline, 3 weeks, 6 weeks, 18 weeks
|
baseline, 3 weeks, 6 weeks, 18 weeks
|
Change scores of EuroQol Quality of Life Scale (EQ-5D)
Time Frame: baseline, 6 weeks
|
baseline, 6 weeks
|
Change scores of Hand strength
Time Frame: baseline, 3 weeks, 6 weeks
|
baseline, 3 weeks, 6 weeks
|
Change scores of Motor activity log (MAL)
Time Frame: baseline, 6 weeks, 18 weeks
|
baseline, 6 weeks, 18 weeks
|
Change scores of ABILHAND Questionnaire
Time Frame: baseline, 6 weeks, 18 weeks
|
baseline, 6 weeks, 18 weeks
|
Change scores of 10-meter walking test
Time Frame: baseline, 6 weeks
|
baseline, 6 weeks
|
Change scores of Nottingham Extended ADL Questionnaire (NEADL)
Time Frame: baseline, 6 weeks, 18 weeks
|
baseline, 6 weeks, 18 weeks
|
Change scores of Adelaide Activities Profile (AAP)
Time Frame: baseline, 6 weeks
|
baseline, 6 weeks
|
Change scores of Accelerometer
Time Frame: baseline, 6 weeks
|
baseline, 6 weeks
|
Change scores of kinematic analysis
Time Frame: baseline, 6 weeks
|
baseline, 6 weeks
|
Change scores of Adverse effects
Time Frame: baseline, 3 weeks, 6 weeks
|
baseline, 3 weeks, 6 weeks
|
Change scores of Algometer
Time Frame: baseline, 6 weeks
|
baseline, 6 weeks
|
Change scores of Revised Nottingham Sensory Assessment (rNSA)
Time Frame: baseline, 6 weeks
|
baseline, 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2015
Primary Completion (Anticipated)
May 1, 2019
Study Completion (Anticipated)
May 1, 2019
Study Registration Dates
First Submitted
May 19, 2015
First Submitted That Met QC Criteria
May 20, 2015
First Posted (Estimate)
May 21, 2015
Study Record Updates
Last Update Posted (Estimate)
July 7, 2016
Last Update Submitted That Met QC Criteria
July 6, 2016
Last Verified
June 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 103-1621A3
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Unilateral Hybrid Intervention
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...WithdrawnHybrid Approach to Unilateral vs. Bilateral Upper Limb Rehabilitation in Subacute and Chronic StrokeCerebrovascular AccidentTaiwan
-
Marco KestingRecruitingComplete Unilateral Cleft LipGermany
-
Instituto Nacional de Cancerologia de MexicoInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto... and other collaboratorsRecruitingBreast NeoplasmMexico
-
Liv Hospital AnkaraCompletedCoronary Artery Disease
-
Uppsala UniversityPBM Sweden ABActive, not recruitingExhaustion Disorder | Clinical BurnoutSweden
-
Université de SherbrookeActive, not recruiting
-
Chinese University of Hong KongCompletedPain, Postoperative | Breast Cancer | MastectomyMalawi, Nigeria
-
Shanghai Jiao Tong University School of MedicineUnknownHeart Failure Due to Coronary Artery DiseaseChina
-
VA Office of Research and DevelopmentCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Massachusetts Eye and Ear InfirmaryNational Eye Institute (NEI)CompletedDiplopia | Binocular Vision Suppression | Binocular; Fusion, With Defective Stereopsis | Monocular DiplopiaUnited States